Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer.

Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer. N Engl J Med. 2015 08 06; 373(6):578-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.